Volume 75, Issue 11, Pages (June 2009)

Slides:



Advertisements
Similar presentations
Volume 62, Issue 6, Pages (December 2002)
Advertisements

Volume 77, Issue 9, Pages (May 2010)
Renal manifestations in Fabry disease and therapeutic options
Renal vitamin D receptor expression and vitamin D renoprotection
Volume 79, Issue 6, Pages (March 2011)
The Case ∣ Acute renal failure and anemia
Driving change: kidney proximal tubule CSF-1 polarizes macrophages
Functional evidence confirmed by histological localization: overlapping expression of erythropoietin and HIF-2α in interstitial fibroblasts of the renal.
Volume 80, Issue 10, Pages (November 2011)
Cytotoxic effect of Shiga toxin-1 on human proximal tubule cells1
John P. Middleton, Patrick H. Pun  Kidney International 
JAK/STAT signaling in renal diseases
Hans-Joachim Anders, Volker Vielhauer, Detlef Schlöndorff 
Volume 55, Issue 4, Pages (April 1999)
Tubular biomarkers to assess progression of diabetic nephropathy
Volume 84, Issue 2, Pages (August 2013)
Volume 77, Issue 9, Pages (May 2010)
Xue-Hui Liu, Achim Aigner, Anton Wellstein, Patricio E. Ray 
Detergent-resistant globotriaosyl ceramide may define verotoxin/glomeruli-restricted hemolytic uremic syndrome pathology  Fahima Khan, François Proulx,
End-stage renal disease in living kidney donors
Bioavailable vitamin D in chronic kidney disease
Volume 77, Issue 1, Pages 5-6 (January 2010)
Infection and chronic allograft dysfunction
Comorbidity and confounding in end-stage renal disease
Alisa K. Hughes, Peter K. Stricklett, Doug Schmid, Donald E. Kohan 
The new role of calcimimetics as vasculotropic agents
Volume 82, Issue 8, Pages (October 2012)
Volume 70, Issue 11, Pages (December 2006)
Florian Lang, Michael Föller  Kidney International 
Volume 76, Issue 2, Pages (July 2009)
Timothy A. Sutton, Pierre C. Dagher  Kidney International 
Xue-Hui Liu, Achim Aigner, Anton Wellstein, Patricio E. Ray 
Macrophages and hypoxia in human chronic kidney disease
Volume 83, Issue 4, Pages (April 2013)
Special deLIVERy: podocyte injury promotes renal angiotensin II generation from liver- derived angiotensinogen  David I. Ortiz-Melo, Robert F. Spurney 
Recruitment of renal tubular epithelial cells expressing verotoxin-1 (Stx1) receptors in HIV-1 transgenic mice with renal disease  Xue-Hui Liu, Clifford.
Driving change: kidney proximal tubule CSF-1 polarizes macrophages
Volume 69, Issue 12, Pages (June 2006)
Volume 85, Issue 5, Pages (May 2014)
Calcium sensing in podocytes
Methods for guideline development
Angiotensin II production and distribution in the kidney: I
Joshua D. Ooi, A. Richard Kitching  Kidney International 
Nephrology Crossword: Glomerulonephritis
Volume 71, Issue 4, Pages (February 2007)
Insulin resistance and hypertension: new insights
Volume 81, Issue 8, Pages (April 2012)
Volume 76, Issue 1, Pages 6-7 (July 2009)
Volume 87, Issue 5, Pages (May 2015)
Volume 80, Issue 7, Pages (October 2011)
Volume 73, Issue 9, Pages (May 2008)
Advances in the pathogenesis of HIV-associated kidney diseases
Paola Romagnani, Hans-Joachim Anders  Kidney International 
Volume 71, Issue 12, Pages (June 2007)
Latest findings in phosphate homeostasis
NODding off in acute kidney injury with progranulin?
Stephen O'Neill, Jeremy Hughes  Kidney International 
The vascular secret of Klotho
Volume 80, Issue 10, Pages (November 2011)
Volume 76, Issue 5, Pages (September 2009)
Volume 72, Issue 4, Pages (August 2007)
Naoki Ikegaya, Akira Hishida, Tatsuo Yamamoto  Kidney International 
Jeffrey Damman, Marc A. Seelen  Kidney International 
Conditions within the kidney that are conducive to C activation.
Volume 76, Issue 9, Pages (November 2009)
T cells and T-cell receptors in acute renal failure
The international realities of live donor kidney transplantation
Tissue protection by erythropoietin: new findings in a moving field
Glomerular binding of anti-dsDNA autoantibodies: The dispute resolved?
HIV and Chemokine Binding to Red Blood Cells—DARC Matters
Presentation transcript:

Volume 75, Issue 11, Pages 1135-1137 (June 2009) Shiga-like toxins and HIV-1 ‘go through’ glycosphingolipids and lipid rafts in renal cells  Patricio E. Ray  Kidney International  Volume 75, Issue 11, Pages 1135-1137 (June 2009) DOI: 10.1038/ki.2009.72 Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 1 Biological model to explain the binding and trafficking of Stx and HIV-1 through renal glomerular and tubular cells. Fluorescent Stx-1 binding studies were performed in 5-μm frozen renal sections harvested from children without renal disease (a), and with HIV-HUS (b), using fluorescein isothiocyanate-labeled Stx-1B subunit (green) as previously described.5 (a) According to Khan et al.,2 Gb3 within detergent-resistant membranes (DRMs) or lipid raft microdomains in the plasma membrane of glomerular endothelial cells is required for the retrograde transport of Stx, and the induction of signaling or cytotoxic events in these cells. (b) A remarkable expression of Gb3 is shown in microcystic renal tubules of a child with HIV-HUS. According to Khan et al.,2 non-DRM plasma membrane Gb3 within tubular epithelial cells mediates binding of Stx and its potential subsequent trafficking to lysosomes for degradation. The HIV envelope glycoprotein gp120 also shows binding to non-DRM Gb3. Gb3, in combination with heparan sulfate proteoglycans,6 the Duffy antigen receptor for chemokines (DARC),10 and other glycosphingolipids7,8 on the cell surface of renal tubular epithelial cells, may enhance the viral infectivity and development of tubulointerstitial lesions in children with HIV-HUS. Kidney International 2009 75, 1135-1137DOI: (10.1038/ki.2009.72) Copyright © 2009 International Society of Nephrology Terms and Conditions